RENEO PHARMACEUTICALS, INC. Shares of Common Stock ($0.0001 par value per share) SALES AGREEMENTSales Agreement • November 13th, 2023 • Reneo Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledNovember 13th, 2023 Company Industry JurisdictionReneo Pharmaceuticals, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Leerink Partners LLC (the “Agent”), as follows: